MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor–1
The oncoprotein transcription factor MYC is a major driver of malignancy and a highly validated but challenging target for the development of anticancer therapies. Novel strategies to inhibit MYC may come from understanding the co-factors it uses to drive pro-tumorigenic gene expression programs, pr...
Váldodahkkit: | , , , , , , , , , , , , , |
---|---|
Materiálatiipa: | Artihkal |
Giella: | English |
Almmustuhtton: |
eLife Sciences Publications Ltd
2021-01-01
|
Ráidu: | eLife |
Fáttát: | |
Liŋkkat: | https://elifesciences.org/articles/60191 |